relation between the serum level of somatomedin A and the bound percentage of labelled somatomedin A to the membrane obtained from lung (r=-0.66, p<0.01) and kidney (r=-0.75, p<0.005) was clearly observed (Fig. 2) These studies have demonstrated that, after fasting, serum levels of somatomedin A decreased with the increase in binding to the plasma membranes from lung and kidney. After feeding, this binding decreased with the increase in the serum level of somatomedin A. A negative correlation between the serum level of somatomedin A and the bound percentage of labelled somatomedin A to the membranes was clearly demonstrated.
These observations suggest that somatomedin down-regulates its own receptor.
In hypophysectomized rats, the binding to the lung and kidney did not increase in spite of the decreased level of somatomedin A. These binding sites did not change after GH treatment. Thus, the regulation of the receptor by somatomedin did not occur in hypophysectomized rats.
It is now well accepted that polypeptide hormone plays a role in modulating its own receptor levels.
A number of hormones appear to down-regulate their receptors, including insulin (Gavin et al. 1974 , Bar et al. 1976 , Olefsky 1976a , TRH (Hinkle and Tashjian 1975) , LH (Conti 1976) , glucagon (Soman and Felig, 1978) and hGH (Lesniak and Roth, 1976) , while instances of induction of up-regulation have been observed in the case of PRL receptors in rat liver (Posner et al. 1975 , Manni et al., 1978 and angiotensin II receptors in kidney (Freedlander et al., 1979) and adrenal glomerulosa (Aguilera et al., 1979) . Up-regulation of insulin receptor and hGH receptor has also been reported in hyperinsulinemic newborns (Neufeld et al., 1978) and in hypophysectomized rabbits and sheep (Posner et al., 1980) . Thus, the influence of a hormone on its own receptor levels might vary depending on the tissue, the prevailing Several investigators have reported that somatomedin down-regulates its receptor. Rosenfeld et al. (1979) observed an increase in the specific binding of somatomedin C to mononuclear cells from placental cord blood, which has a lower level of somatomedin C than that of adults. Hizuka et al. (1981) demonstrated an inverse correlation between serum levels of somatomedin A and labelled somatomedin A binding to membrane fractions from kidney of growing rats. Rosenfeld and Hintz (1980) reported that somatomedin can induce the loss of specific somatomedin C receptors on cultured 1M-9 lymphocytes. Under in vivo conditions, they observed that treatment of hypopituitary dwarfs with hGH results in a significant decline in the specific binding of 125I-somatomedin C, with an increase in the plasma somatomedin level (Rosenfeld et al., 1981) , and the decrease in specific binding was predominantly secondary to a reduced number of somatomedin C receptor sites per cell. After hypophysectomy, serum levels of somatomedin decreased. However we observed no increase in binding both in either lung or kidney membrane fractions. This might be partly due to the lack not only of growth hormone but also of other pituitary hormones. However, the mechanism of this observation is unclear. We observed an increase in binding after fasting which was secondary to an increase in affinity to the binding sites. The increase in the affinity of insulin binding sites after fasting has also been reported utilizing adipocytes and skeletal muscle in starved rats (Olefsky, 1976b , Brady et al., 1981 . The detailed mechanism of this regulation needs to be clarified. TAKANO et al. Endocrinol. Japon. October 1981 
